Ming Gu

1.8k total citations
40 papers, 1.5k citations indexed

About

Ming Gu is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Ming Gu has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Surgery and 7 papers in Epidemiology. Recurrent topics in Ming Gu's work include Cholesterol and Lipid Metabolism (7 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). Ming Gu is often cited by papers focused on Cholesterol and Lipid Metabolism (7 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). Ming Gu collaborates with scholars based in China, United States and Japan. Ming Gu's co-authors include Shengjie Fan, Cheng Huang, Guang Ji, Yunsong Liu, Yongsheng Zhou, Cheng Huang, Xiong Lu, Qingchun Tong, Zhiqin Zhou and Chunyang Xiong and has published in prestigious journals such as Advanced Materials, PLoS ONE and Biomaterials.

In The Last Decade

Ming Gu

39 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Gu China 22 519 288 209 190 173 40 1.5k
Hyung‐Sub Kang South Korea 18 473 0.9× 195 0.7× 120 0.6× 113 0.6× 144 0.8× 58 1.4k
Yuting Li China 22 512 1.0× 334 1.2× 161 0.8× 90 0.5× 63 0.4× 64 1.6k
Sei‐Jung Lee South Korea 29 1.0k 2.0× 92 0.3× 189 0.9× 261 1.4× 155 0.9× 95 2.2k
Amitava Das India 28 702 1.4× 193 0.7× 250 1.2× 124 0.7× 70 0.4× 73 2.2k
Elsa C. Chan Australia 23 620 1.2× 122 0.4× 149 0.7× 338 1.8× 56 0.3× 43 1.8k
Seong Lin Teoh Malaysia 26 557 1.1× 92 0.3× 101 0.5× 214 1.1× 130 0.8× 83 2.0k
Vengadeshprabhu Karuppagounder Japan 23 501 1.0× 102 0.4× 160 0.8× 150 0.8× 119 0.7× 53 1.5k
Dinesh Kumar India 28 585 1.1× 106 0.4× 118 0.6× 431 2.3× 190 1.1× 74 2.3k
Ki‐Suk Kim South Korea 20 528 1.0× 218 0.8× 168 0.8× 194 1.0× 88 0.5× 58 1.6k
Guanwei Fan China 32 1.2k 2.4× 205 0.7× 253 1.2× 119 0.6× 369 2.1× 77 2.7k

Countries citing papers authored by Ming Gu

Since Specialization
Citations

This map shows the geographic impact of Ming Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Gu more than expected).

Fields of papers citing papers by Ming Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Gu. The network helps show where Ming Gu may publish in the future.

Co-authorship network of co-authors of Ming Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Gu. A scholar is included among the top collaborators of Ming Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Gu. Ming Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Ming, Yujun Chen, Yiping Li, et al.. (2025). Unlocking the potential of atractylenolide II: Mitigating non-alcoholic fatty liver disease through farnesoid X receptor-endoplasmic reticulum stress interplay. Journal of Pharmaceutical Analysis. 15(12). 101318–101318.
2.
Gu, Ming, Yujun Chen, Yaru Feng, & Zhipeng Tang. (2024). LanGui tea, an herbal medicine formula, protects against binge alcohol-induced acute liver injury by activating AMPK-NLRP3 signaling. Chinese Medicine. 19(1). 41–41. 6 indexed citations
3.
Gu, Ming, Yang Liu, Wenhui Zheng, et al.. (2024). Combined targeting of senescent cells and senescent macrophages: A new idea for integrated treatment of lung cancer. Seminars in Cancer Biology. 106-107. 43–57. 18 indexed citations
4.
Gu, Ming, Yaru Feng, Yujun Chen, Shengjie Fan, & Cheng Huang. (2023). Deoxyschizandrin ameliorates obesity and non‐alcoholic fatty liver disease: Involvement of dual Farnesyl X receptor/G protein‐coupled bile acid receptor 1 activation and leptin sensitization. Phytotherapy Research. 37(7). 2771–2786. 8 indexed citations
5.
Ruan, Lina, Yue Wang, Ming Gu, et al.. (2022). Baicalein exerts anxiolytic and antinociceptive effects in a mouse model of posttraumatic stress disorder: Involvement of the serotonergic system and spinal delta-opioid receptors. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 122. 110689–110689. 10 indexed citations
6.
Chen, Yujun, Haiyan Song, Ziwei Zhang, et al.. (2021). Extracts of Vine Tea Improve Diet-Induced Non-Alcoholic Steatohepatitis Through AMPK-LXRα Signaling. Frontiers in Pharmacology. 12. 711763–711763. 10 indexed citations
7.
Gu, Ming, Haiyan Song, Yiping Li, et al.. (2020). Extract of Schisandra chinensis fruit protects against metabolic dysfunction in high‐fat diet induced obese mice via FXR activation. Phytotherapy Research. 34(11). 3063–3077. 13 indexed citations
8.
Gu, Ming, Wenhui Zheng, Mingdi Zhang, et al.. (2020). LncRNA NONHSAT141924 promotes paclitaxel chemotherapy resistance through p-CREB/Bcl-2 apoptosis signaling pathway in breast cancer. Journal of Cancer. 11(12). 3645–3654. 32 indexed citations
9.
Gu, Ming, Wenhui Zheng, Mingdi Zhang, et al.. (2019). Downregulation of RAI14 inhibits the proliferation and invasion of breast cancer cells. Journal of Cancer. 10(25). 6341–6348. 14 indexed citations
10.
Gu, Ming, Zhang Shi-ying, Yuanyuan Zhao, et al.. (2017). Cycloastragenol improves hepatic steatosis by activating farnesoid X receptor signalling. Pharmacological Research. 121. 22–32. 46 indexed citations
11.
Gu, Ming, Jinwen Huang, Yuanyuan Zhao, et al.. (2016). Silymarin Ameliorates Metabolic Dysfunction Associated with Diet-Induced Obesity via Activation of Farnesyl X Receptor. Frontiers in Pharmacology. 7. 345–345. 62 indexed citations
12.
Zhang, Yu, Ming Gu, Feng Li, et al.. (2016). Dietary component isorhamnetin is a PPARγ antagonist and ameliorates metabolic disorders induced by diet or leptin deficiency. Scientific Reports. 6(1). 19288–19288. 64 indexed citations
13.
Liu, Yunsong, Hao Liu, Ming Gu, et al.. (2014). The effect of simvastatin on chemotactic capability of SDF-1α and the promotion of bone regeneration. Biomaterials. 35(15). 4489–4498. 95 indexed citations
14.
Gu, Ming, Yunsong Liu, Tong Chen, et al.. (2014). Is Graphene a Promising Nano-Material for Promoting Surface Modification of Implants or Scaffold Materials in Bone Tissue Engineering?. Tissue Engineering Part B Reviews. 20(5). 477–491. 94 indexed citations
15.
Gu, Ming, et al.. (2013). Extracts of Rhizoma Polygonati Odorati Prevent High-Fat Diet-Induced Metabolic Disorders in C57BL/6 Mice. PLoS ONE. 8(11). e81724–e81724. 32 indexed citations
16.
Li, Jing, Yu Zhang, Shengjie Fan, et al.. (2013). Preventive and ameliorating effects of citrus d-limonene on dyslipidemia and hyperglycemia in mice with high-fat diet-induced obesity. European Journal of Pharmacology. 715(1-3). 46–55. 114 indexed citations
17.
18.
Fan, Shengjie, Yu Zhang, Na Hu, et al.. (2012). Extract of Kuding Tea Prevents High-Fat Diet-Induced Metabolic Disorders in C57BL/6 Mice via Liver X Receptor (LXR) β Antagonism. PLoS ONE. 7(12). e51007–e51007. 58 indexed citations
19.
Gu, Ming & Martin W. Wessendorf. (2007). Endomorphin‐2‐immunoreactive fibers selectively appose serotonergic neuronal somata in the rostral ventral medial medulla. The Journal of Comparative Neurology. 502(5). 701–713. 13 indexed citations
20.
Xie, Jing, Yinggang Zhou, Lucy Dey, et al.. (2002). Ginseng berry reduces blood glucose and body weight in db/db mice. Phytomedicine. 9(3). 254–258. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hyung‐Sub Kang Breakdown of academic impact, for papers by Yuting Li Breakdown of academic impact, for papers by Sei‐Jung Lee Breakdown of academic impact, for papers by Amitava Das Breakdown of academic impact, for papers by Elsa C. Chan Breakdown of academic impact, for papers by Seong Lin Teoh Breakdown of academic impact, for papers by Vengadeshprabhu Karuppagounder Breakdown of academic impact, for papers by Dinesh Kumar Breakdown of academic impact, for papers by Ki‐Suk Kim Breakdown of academic impact, for papers by Guanwei Fan
Rankless by CCL
2026